NOKOMIS, Fla.--(BUSINESS WIRE)-- <\/p>\n
As Rainbow BioSciences, the biotech subsidiary of Rainbow Coral Corp. (RBCC), works to acquire licensing for commercial use of NASA-developed stem cell expansion technology, the company received good news from a Wall Street analysts forecast on Wednesday. <\/p>\n
Writing for Seeking Alpha, George Kesarios predicted major growth for the global stem cell market in coming years. Its estimated that the market will be worth about $64 billion by 2015, up from $21.5 billion in 2010. <\/p>\n
Kesarios attributed the growth largely to a potential revolution in drug companies research and development made possible by an abundance of induced pluripotent stem cells. <\/p>\n
With these stem cells, scientists can actually create working facsimiles of living human tissue, introduce diseases and observe how they unfold under a microscope, said RBCC CEO Patrick Brown. Spending a decade on research only to discover in trials that a drug doesnt work could become a thing of the past. Stem cells hold the key to the future of profitable, effective drug development. <\/p>\n
Thats why RBCC has engaged Regenetech in discussions regarding the potential acquisition of a license to perform cell expansion using that companys Rotary Cell Culture SystemTM. <\/p>\n
The Rotary Cell Culture SystemTM is a rotating-wall bioreactor designed to facilitate the growth of human cells in simulated weightlessness. Cell cultures, including stem cells, grown inside the bioreactor look and function much closer to human cells grown within the body than the flat cell cultures grown in Petri dishes. <\/p>\n
The potential for stem cells expansion using this unique culturing system originally devised for the space program is incredible, Brown said. Every cell researcher in the world is going to want access to this technology. <\/p>\n
RBCC plans to offer new technology to compete in the stem-cell research industry alongside Amgen, Inc. (AMGN), Celgene Corporation (CELG), Genzyme Corp. (NASDAQ:GENZ) and Gilead Sciences Inc. (GILD). <\/p>\n
For more information on Rainbow BioSciences, please visit http:\/\/www.rainbowbiosciences.com\/investors.html<\/a>. <\/p>\n<\/p>\n Originally posted here: NOKOMIS, Fla.--(BUSINESS WIRE)-- As Rainbow BioSciences, the biotech subsidiary of Rainbow Coral Corp. (RBCC), works to acquire licensing for commercial use of NASA-developed stem cell expansion technology, the company received good news from a Wall Street analysts forecast on Wednesday. Continue reading
\nRBCC: Stem Cell Market Poised for Billion-Dollar Growth<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"